Deallus welcomes George Gu, Principal & Head of China, Shanghai
Deallus is delighted to announce that George Gu joined our team on the 6th of April. Medical Doctor by training – focusing on Radiation Oncology – George has spent the last 7 years working with various consulting and start-up companies, gaining valuable experience in medical internet and genomic profiling companies.
George is a medical doctor, licensed by The Chinese Ministry Of Health, and has more than 18 years experience working in multinational pharmaceutical and medical device companies, including AstraZeneca, Wyeth, Roche Diagnostic, and Eli Lilly. Throughout his career, George took on roles focusing on clinical research, sales management, marketing, new product launch and commercial excellence. George also has substantial experience in leading start-up companies, government-based continued education organisations and consulting firms.
In his new role at Deallus, he will lead our China expansion, strengthen the therapeutic areas he focuses on and have a key role in further expanding our capabilities within this region.
His expertise spans across various therapeutic areas such as Oncology, Immunology, Genetic testing, Anti-infective, Surgery, Cardiovascular, Diabetes, Immunosuppressant, Pain Management, Osteoporosis and Respiratory. He is recognised by clients and peers as a key leader with functional expertise across Market Access, Pricing strategy, New Product Launch, Portfolio Management, Commercial excellence, Digital Transformation, Innovative Marketing and Medical Leadership.
George has program training certification from John Hopkins Bloomberg School of Public Health for Hospital Management and Medical Leadership. He has a master degree, International MBA from Hong Kong University, and a clinical medicine bachelor degree from Fu Dan University Medical School.
“I am excited to join this incredible team. I am impressed by the Deallus culture, especially as I can feel that it has a distinctive spirit of cooperating as a global team. Deallus has excellent staff owning an outstanding academic capability across diverse therapeutic expertise. I cherish the hope that, together with my global colleagues, I will bring new value for Deallus’ clients to build on competitive advantage by bridging China to Deallus’ global spread and vice versa.”
Jesper Nissen, Senior Principal, UK adds:
“We’re privileged to have George join the Deallus team. George brings invaluable expertise in Oncology and Clinical Research, building on past leadership roles, and leveraging his impressive portfolio of medical experience. We’re delighted to see, through the addition of George to our leadership team, an upscaling of Deallus’ account leadership capacity and build on our geographic expansion, whilst strengthening the company’s functional capabilities particularly in New Product Launch and Commercial Excellence. I’m excited to introduce George to our network of clients!”
